𝕏 Share



Radical Cures

A charity proving demand for disease cures — so investors fund the prize pools that motivate researchers to deliver them.

ANCHOR DISEASE — PHASE 1 NOW OPEN

Colour Vision Deficiency

350 million people worldwide can't see colour properly. That's 1 in 12 men and 1 in 200 women. No cure exists today — but gene therapy research shows it's possible. We just need to prove the demand.

74

Can you see the number 74? People with colour vision deficiency often can't.

350M
people affected
0
cures exist
0
registered so far

Free to register. Every registration proves demand — demand attracts investors — investors fund the prize — prize motivates a cure.

350M+
People with Colour Blindness
160+
Diseases Listed
0
Supporters Registered
$0 paid
Until Cures Are Proven

Our Mission

Medical research is broken. Researchers are funded to study diseases, not cure them. Grant money runs out, papers get published, and patients keep waiting.

We're building a different model: disease-specific prize pools, funded by the public, that only pay out when a verified cure is delivered. No cure, no payment. We're starting as a charity — proving that the demand for cures is real, massive, and fundable.

How It Works — 4 Phases

1

Register & Donate (Now)

ACTIVE PHASE

People with colour vision deficiency — or anyone who wants a cure to exist — register their support and make a small charitable donation. This proves real, quantifiable demand to potential investors. You're not just hoping for a cure. You're proving the world wants one.

2

Attract Investors

With thousands of registered supporters and a growing donation base, we present the data to impact investors and philanthropists. The pitch is simple: here's the proven demand, here's the model, here's your chance to grow the prize pool and earn returns if a cure is found.

3

Research Race Begins

As the prize pool grows large enough to matter, research teams compete to claim it. No grant proposals, no committees, no bureaucracy. One objective: develop a verified cure. The bigger the pool, the more serious the competition.

4

Cure Verified, Prize Claimed

A researcher submits a verified cure. Independent scientific review confirms it. The entire prize pool is paid out. The cure is licensed under OMAR — open access to humanity, with 10% commercial royalties flowing back to fund future disease research.

Benefits for Everyone

For Donors

  • Turn tax deductions into medical miracles
  • 100% of funds laser-focused on cures
  • Zero waste, maximum impact
  • Write yourself into medical history

For Investors

  • Returns with real-world meaning
  • Spread risk across breakthrough initiatives
  • Pay only for proven solutions
  • Profit meets purpose

For Researchers

  • Funding without bureaucratic handcuffs
  • Complete research autonomy
  • Get paid like a medical rockstar
  • Global recognition for game-changing work
Whitepaper

Register Your Support

Phase 1 — Proving demand. Free to register. Every person counted builds the case for investors.

Why Register?

  • Your registration is public proof of demand. We use this data to attract impact investors to the prize pool.
  • An optional small donation (any amount) signals financial demand — the most powerful signal to investors.
  • You'll be notified when the prize pool hits milestones and when a cure is eventually claimed.
  • Share with others who have colour vision deficiency — every registration moves us closer to a funded prize.
0
people have registered their support
Target: 10,000 registrations to begin investor outreach

Your information is never sold. We'll only contact you about this cure initiative.

Donate or Invest in Breakthrough Cures

Choose to either donate or invest. Donations help accelerate research, while investments give you a chance to earn a return when a cure is found.

Current Prize Pool

Select a disease below to see details

Select a Disease to Support

Select a disease to see details and funding progress

Credit Card

Secure payment via Stripe

Open Medical Advancement Royalty (OMAR)

Balancing Open Access with Sustainable Funding

All cures funded through our platform are shared under our Open Medical Advancement Royalty (OMAR), creating a new paradigm that benefits everyone.

Open Access

Medical breakthroughs are made openly accessible to humanity, maximizing their impact and reaching patients faster.

Sustainable Funding

Commercial implementers contribute 10% of related revenue back to research, creating a self-sustaining cycle.

Researcher Recognition

Scientists receive both proper attribution and financial compensation for their breakthrough discoveries.

Win-Win Model

Patients get access to cures, researchers get funded, and the cycle continues for future medical innovations.

Contact Us

Have questions? We're here to help!

Funding Progress